Oxford Nanopore’s MinION hand-held DNA reader, which can sequence genomes in as little as five years', will be put to the test in a publicly-funded trial focusing on hospital-acquired pneumonia by scientists at the University of East Anglia. Backed by the National Institute for Health Research, the 18-month trial will seek the most effective diagnostic tool for pneumonia, which is responsible for a quarter of all intensive care infection cases, with the aim of fast-tracking approval for NHS use in a matter of days time.
Oxford Nanopore’s MinION hand-held DNA reader, which can sequence genomes in a matter of days, will be put to the test in a publicly-funded trial focusing on hospital-acquired pneumonia by scientists at the University of East Anglia. Backed by the National Institute for Health Research, the 18-month trial will seek the most effective diagnostic tool for pneumonia, which is responsible for a quarter of all intensive care infection cases, with the aim of fast-tracking approval for NHS use in as little as five years' time.